Delivery Order SPE2DB22D2206-SPE2DB25FJD84
Award Date 7/30/25
Potential Completion Date 7/31/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,980.90 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed price delivery order, issued without set-aside designation, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication primarily used to treat autoimmune and inflammatory conditions including...
- The Defense Logistics Agency awarded a delivery order valued at $8,894.37 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on August 25, 2025, with completion scheduled for August 26, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $25,456.25 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication commonly used to treat autoimmune...
- The Defense Logistics Agency awarded a $15,104.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on May 16, 2025, with an ultimate completion date of May 19, 2025. This contract is a non-set-aside award and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic...
- The Defense Logistics Agency awarded a $7,021.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML autoinjector on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing...
- The Defense Logistics Agency awarded a $21,972.38 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TALTZ 80 mg/mL autoinjectors. This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a $5,392.46 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical supplies. This non-set-aside, firm fixed price delivery order was executed on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant medication used to treat autoimmune inflammatory...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,670.76 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL AutoInjector (2-pack) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used in the treatment of autoimmune...
- The Defense Logistics Agency awarded a $78,465.50 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used primarily to treat autoimmune conditions including psoriasis,...
- The Defense Logistics Agency awarded a delivery order valued at $6,641.24 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis,...